Kynamro Interactions
There are 318 drugs known to interact with Kynamro (mipomersen), along with 2 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 317 are major, and 1 is moderate.
- View all 318 medications that may interact with Kynamro
- View Kynamro alcohol/food interactions (1)
- View Kynamro disease interactions (2)
Most frequently checked interactions
View interaction reports for Kynamro (mipomersen) and the medicines listed below.
- Actemra (tocilizumab)
- Adcetris (brentuximab)
- Austedo (deutetrabenazine)
- Blincyto (blinatumomab)
- Bosulif (bosutinib)
- CellCept (mycophenolate mofetil)
- Corlanor (ivabradine)
- Cosentyx (secukinumab)
- Creon (pancrelipase)
- Esbriet (pirfenidone)
- Feiba (anti-inhibitor coagulant complex)
- Gleevec (imatinib)
- Hemlibra (emicizumab)
- Imbruvica (ibrutinib)
- Inderal (propranolol)
- Isentress (raltegravir)
- Juxtapid (lomitapide)
- Jynarque (tolvaptan)
- Kalydeco (ivacaftor)
- Luxturna (voretigene neparvovec ophthalmic)
- Ocrevus (ocrelizumab)
- Ofev (nintedanib)
- Oncovin (vincristine)
- Procysbi (cysteamine)
- Promacta (eltrombopag)
- Pulmozyme (dornase alfa)
- Rapamune (sirolimus)
- Repatha (evolocumab)
- Stalevo (carbidopa / entacapone / levodopa)
- Thalomid (thalidomide)
Kynamro alcohol/food interactions
There is 1 alcohol/food interaction with Kynamro (mipomersen).
Kynamro disease interactions
There are 2 disease interactions with Kynamro (mipomersen) which include:
Report options
QR code containing a link to this page
More about Kynamro (mipomersen)
- Kynamro consumer information
- Compare alternatives
- Reviews (1)
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: miscellaneous antihyperlipidemic agents
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.